Lipocine Inc. 8-K Filing: Key Updates & Compliance Report - December 2024
Based on the provided financial report section, here are the key pieces of information extracted:
- Entity Information:
- Name: Lipocine Inc.
- CIK (Central Index Key): 0001535955
- SEC File Number: 001-36357
- EIN (Employer Identification Number): 99-0370688
- Address: 675 Arapeen Drive, Suite 202, Salt Lake City, UT 84108
- Phone Number: (801) 994-7383
- Report Type:
- Filing Type: 8-K (Current Report)
- Filing Date:
- Date of Report: December 17, 2024
- Common Stock Details:
- Par Value: $0.0001 per share
- Ticker Symbol: LPCN
- Exchange: NASDAQ
- Context & Measurement:
- Report Context: As of December 17, 2024
- Currency: USD (United States Dollar)
- Units of Measurement: Shares and USD per Share
- XBRL Information:
- The report is structured in XBRL format, which allows for better data analysis and extraction.
Insights:
- The report indicates that Lipocine Inc. is in compliance with SEC filing requirements, as evidenced by the timely submission of an 8-K.
- The company is publicly traded on NASDAQ under the ticker LPCN, suggesting it is subject to market scrutiny and regulatory oversight.
- The details about the share structure (par value) and the filing type imply that the company may be reporting significant events or changes that are relevant to shareholders and investors.
- The presence of specific XML tags indicates the formality and structure of the filing, enhancing its credibility and the ease of data processing.
This information is crucial for investors, analysts, and stakeholders monitoring the company's performance and developments.